All Articles

Researchers identified an association between nutritional status, treatment protocols, and survival in patients with advanced non–small-cell lung cancer.

Recently released study findings on PD-1/PD-L1 immunotherapy in young and elderly patients with metastatic NSCLC found the treatment is safe and effective in both patient cohorts.

Navigating patients with hematologic malignancies is fraught with its own unique challenges. Here’s what you need to know.

Scalp cooling devices can provide patients with an opportunity to prevent hair loss during chemotherapy treatment, and to potentially finish treatment without anyone else knowing about it.

The National Acuity Initiative presents their findings from a scoping review of the literature. These results informed the creation of case studies on which the acuity tool will be tested and validated.

Next-generation sequencing for targetable mutations in lung cancer is as accurate as single-gene testing with minimal increase in testing cost.

Released study results indicate that an interval of ≤50 days from diagnosis to treatment significantly improves outcomes in patients with early-stage lung cancer.